Later, in 1991, Braak and Braak found a characteristic distribution pattern of tau-containing neurofibrillary changes in AD brains (4), thus creating an eponymous staging system which led to an understanding of tau spatiotemporal spread as a causal factor underlying disease progression and severity. Here, MAPT is linked to Alzheimer disease.